✦ LIBER ✦

Growth hormone treatment of infants with chronic kidney disease: requirement, efficacy, and safety

✍ Scribed by Dieter Haffner; Dagmar-Christiane Fischer

Publisher: Springer
Year: 2009
Tongue: English
Weight: 95 KB
Volume: 24
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-009-1192-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obstacles to the prescribing of growth h

Obstacles to the prescribing of growth hormone in children with chronic kidney disease

✍ Larry A. Greenbaum; Guillermo Hidalgo; Deepa Chand; Myra Chiang; Katherine Dell; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 94 KB

Growth hormone treatment started in the

Growth hormone treatment started in the first year of life in infants with chronic renal failure

✍ Francesca Mencarelli; Daniela Kiepe; Giovanna Leozappa; Gilda Stringini; Marco C 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 234 KB

Etiology and treatment of growth retarda

Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective

✍ Richard N. Fine 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 223 KB

Effect of growth hormone treatment on se

Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease

✍ Hans C. Andersson; Thomas Markello; Jerry A. Schneider; William A. Gahl 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 119 KB

Efficacy and safety of interferon alfa t

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

✍ Luca Todros; Giorgio Saracco; Marilena Durazzo; Maria Lorena Abate; Giovanni Tou 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Interferon alfa (IFN) therapy is efficacious in chronic viral hepatitides. It may, however, cause adverse immunologic reactions in patients with concomitant autoimmune phenomena. A minority of patients with chronic type C hepatitis have antibodies against liver and kidney microsomes (anti-LKM) in se

Assessment and treatment of short statur

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement

✍ John D. Mahan; Bradley A. Warady; Consensus Committee 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 409 KB